Market revenue in 2023 | USD 2,494.8 million |
Market revenue in 2030 | USD 4,493.8 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Mammalian source |
Fastest growing segment | Mammalian Source |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Microbial Source, Mammalian Source, Other Source |
Key market players worldwide | WuXi Biologics (Cayman) Inc, FUJIFILM Holdings Corp, AGC Biologics, Thermo Fisher Scientific Inc, Curia, Genscript Biotech Corp Class H, Boehringer Ingelheim Pharma, Abzena, JSR Corp, Bionova Scientific |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract development market will help companies and investors design strategic landscapes.
Mammalian source was the largest segment with a revenue share of 56.25% in 2023. Horizon Databook has segmented the Europe biologics contract development market based on microbial source, mammalian source, other source covering the revenue growth of each sub-segment from 2018 to 2030.
Europe was the second largest contributor to the biologics contract development market, with a 39.63% share in 2019. Countries such as Germany and the UK have high patient population and advanced medical expertise.
Doctors in the country recommend trials with high chances of patient recruitment, benefiting research as well as patients. Regulations are formulated to ensure safety, rights, and proper reimbursement for volunteers.
With clearer protocols and increased funding, Europe is expected to be a promising region for clinical trials. Factors such as improved access to treatment-naïve patient pool, higher concentration of patients near sites, cheap labor, and close relationship between doctors & patients are driving the clinical research market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biologics contract development market, including forecasts for subscribers. This continent databook contains high-level insights into Europe biologics contract development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account